MiR-27a has, for example, exhibited oncogenic activity in breast cancer by down-regulating zinc finger ZBTB10 protein leading to over-expression of pro-survival and pro-angiogenic genes including survivin, VEGF, VEGF receptor 1 (VEGFR1) [36]. This evidence concerns the gene VEGFA and breast cancer.